Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes ...

A key clause in Microsoft and OpenAI's deal embodies the raging divide between AGI true believers and those who think it's ...

OpenAI is the world's leading AI startup. For how long will depend on how well it fends off multi-front attacks from ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya Nade ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

After laying off 9000 workers, Microsoft touts itself as saving $500 million in AI efficiency.

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Viome partners with Microsoft to scale its RNA-based health platform, using AI and cloud computing to deliver personalized ...